I‐Tsu Chyuan
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Immunology top 10%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Systemic Lupus Erythematosus Research 5
-
- T-cell and B-cell Immunology 4
- Co-authors
- Ping‐Ning Hsu (19 shared papers)Hong‐Tai Tzeng (5 shared papers)Jenn‐Haung Lai (2 shared papers)Hwei-Fang Tsai (9 shared papers)Chien‐Sheng Wu (13 shared papers)Ji-Yih Chen (2 shared papers)Hsiu‐Jung Liao (8 shared papers)Ching‐Liang Chu (3 shared papers)
In The Last Decade
I‐Tsu Chyuan
29 papers receiving 849 citations
Peers
Comparison fields: 5 of 74
- Rheumatology 170
- Immunology 183
- Periodontics 37
- Oncology 108
- Drug Discovery 1
Countries citing papers authored by I‐Tsu Chyuan
This map shows the geographic impact of I‐Tsu Chyuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Tsu Chyuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Tsu Chyuan more than expected).
Fields of papers citing papers by I‐Tsu Chyuan
This network shows the impact of papers produced by I‐Tsu Chyuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Tsu Chyuan. The network helps show where I‐Tsu Chyuan may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Tsu Chyuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 78 | |
| 2 | 2019 | 74 | |
| 3 | 2021 | 68 | |
| 4 | 2021 | 56 | |
| 5 | 2014 | 54 | |
| 6 | 2019 | 51 | |
| 7 | 2018 | 45 | |
| 8 | 2019 | 43 | |
| 9 | 2015 | 41 | |
| 10 | 2017 | 38 | |
| 11 | 2018 | 37 | |
| 12 | 2019 | 36 | |
| 13 | 2015 | 31 | |
| 14 | 2015 | 29 | |
| 15 | 2019 | 29 | |
| 16 | 2015 | 23 | |
| 17 | 2021 | 20 | |
| 18 | 2013 | 18 | |
| 19 | 2017 | 17 | |
| 20 | 2020 | 16 |
About I‐Tsu Chyuan
I‐Tsu Chyuan is a scholar working on Rheumatology, Immunology, Epidemiology, Periodontics and Complementary and alternative medicine, having authored 30 papers that have together received 865 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (5 papers), Systemic Lupus Erythematosus Research (5 papers), T-cell and B-cell Immunology (4 papers), Oral microbiology and periodontitis research (2 papers), Inflammatory Bowel Disease (2 papers), Protein Tyrosine Phosphatases (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Multiple Sclerosis Research Studies (2 papers). The work is most often cited by research in Rheumatology (170 citations), Immunology (183 citations), Periodontics (37 citations), Oncology (108 citations) and Drug Discovery (1 citation). I‐Tsu Chyuan has collaborated with scholars based in Taiwan, Japan and Thailand. Frequent co-authors include Ping‐Ning Hsu, Hong‐Tai Tzeng, Jenn‐Haung Lai, Hwei-Fang Tsai, Chien‐Sheng Wu, Ji-Yih Chen, Hsiu‐Jung Liao, Ching‐Liang Chu, Pei‐Jer Chen and Wei‐Yu Chen. Their work appears in journals such as Cellular and Molecular Immunology, Lara D. Veeken, Biomolecules, Biochemical Pharmacology and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.